BNP Paribas Financial Markets’s VolitionRx Ltd VNRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19 Buy
14
+1
+8% +$2 ﹤0.01% 5853
2026
Q1
$54 Hold
13
﹤0.01% 5721
2025
Q4
$68 Hold
13
﹤0.01% 5630
2025
Q3
$180 Hold
13
﹤0.01% 5397
2025
Q2
$201 Hold
13
﹤0.01% 5284
2025
Q1
$151 Hold
13
﹤0.01% 5234
2024
Q4
$159 Hold
13
﹤0.01% 5250
2024
Q3
$159 Hold
13
﹤0.01% 4051
2024
Q2
$160 Hold
13
﹤0.01% 3948
2024
Q1
$201 Hold
13
﹤0.01% 3948
2023
Q4
$190 Hold
13
﹤0.01% 3931
2023
Q3
$183 Hold
13
﹤0.01% 3828
2023
Q2
$368 Hold
13
﹤0.01% 3807
2023
Q1
$506 Hold
13
﹤0.01% 3720
2022
Q4
$644 Hold
13
﹤0.01% 3845
2022
Q3
$360 Sell
13
-5
-28% -$189 ﹤0.01% 4554
2022
Q2
$718 Buy
18
+1
+6% +$50 ﹤0.01% 3931
2022
Q1
$1.04K Hold
17
﹤0.01% 3955
2021
Q4
$1.09K Sell
17
-3
-15% -$205 ﹤0.01% 4047
2021
Q3
$1.22K Buy
20
+4
+25% +$253 ﹤0.01% 3852
2021
Q2
$1.02K Sell
16
-159
-91% -$10.8K ﹤0.01% 3942
2021
Q1
$13.3K Sell
175
-48
-22% -$4.12K ﹤0.01% 3809
2020
Q4
$17.3K Sell
223
-54
-19% -$3.72K ﹤0.01% 3871
2020
Q3
$17.8K Buy
277
+233
+530% +$15.8K ﹤0.01% 3863
2020
Q2
$3.43K Buy
+44
New +$3.18K ﹤0.01% 4118

Other funds holding VNRX

BNP Paribas Financial Markets's VNRX Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its VolitionRx Ltd (VNRX) stake by 7.7% in Q2 2026, buying an estimated $2 and bringing the position to 14 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #5853.

BNP Paribas Financial Markets first reported a position in VNRX in Q2 2020 and has held it in 25 quarters since. The position peaked at $17.8K in Q3 2020. 19 funds tracked by Wall St. Rank hold VNRX as of Q2 2026.

  • BNP Paribas Financial Markets held 14 shares of VolitionRx Ltd worth $19 as of Q2 2026.
  • BNP Paribas Financial Markets bought 1 VolitionRx Ltd share in Q2 2026, an estimated $2.
  • VolitionRx Ltd made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5853 holding.
  • BNP Paribas Financial Markets first reported a position in VolitionRx Ltd in Q2 2020 and has held it in 25 quarters since.
  • BNP Paribas Financial Markets's VolitionRx Ltd position peaked at $17.8K in Q3 2020.
  • 19 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.